Tositumomab and malignant neoplasm progression Patient Reports February 11, 2012
Tositumomab Side Effects Report #5134681-4
Tositumomab side effect was reported by a Physician from UNITED STATES on Jan 26, 2005. Male patient, 62 years of age, weighting 193.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab. After drug was administered, patient experienced the following side effects: cerebral infarction, malignant neoplasm progression, metastasis, pleural effusion, prostate cancer
. Tositumomab dosage: unknown. During the same period patient was treated with IODINE I, IODINE I. Patient died on 09/28/2004.
Tositumomab and malignant neoplasm progression 